(±)-Epibatidine (hydrochloride) (Synonyms:(±)-地棘蛙素;CMI 545 dihydrochloride;(±)-Epibatidine dihydrochloride)
目录号 : KCM11831 CAS No. : 162885-01-0 纯度 : ≥98%
(±)-Epibatidine is an alkaloid that has been found in Ecuadoran poison frog (E. tricolor) skin extracts and an agonist of α4β2 subunit-containing nicotinic acetylcholine receptors (nAChRs; K = 43 pM). It is selective for α4β2 subunit-containing nAChRs over α7 nAChRs (K = 230 nM). (±)-Epibatidine enhances Rb flux in IMR-32 cells (EC = 7 nM) and induces dopamine release from rat striatal slices (EC = 0.4 nM), effects that can be reduced by the nAChR antagonist mecamylamine . In vivo, (±)-epibatidine induces analgesia in the hot plate test and the Straub-tail response in mice (EDs = 0.005 and 0.02 mg/kg, respectively).
规格 价格 是否有货 数量
1mg
In-stock
5mg
In-stock
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

(±)-Epibatidine (CMI 545) dihydrochloride is an agonist of nicotinic with potent analgetic activity. (±)-Epibatidine (CMI 545) dihydrochloride is an alkaloid originally characterized from frog skin. (±)-Epibatidine (CMI 545) dihydrochloride have little or no activity at a variety of other central receptors, including opioid receptors, muscarinic receptors, adrenergic receptors, dopamine receptors, serotonin receptors, and gamma-aminobutyric acid receptors.

分子式
C11H13ClN2.2HCl
分子量
281.61
CAS号
162885-01-0
中文名称
(±)-地棘蛙素;rel-(1R,2R,4S)-2-(6-氯-3-吡啶基)-7-氮杂双环[2.2.1]庚烷二盐酸盐
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度 mg/ml;

DMSO母液配制方法 mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。